One significant challenge is the variation in regulatory frameworks across countries. Different nations have different safety standards, which can complicate the commercialization of new nanotechnologies. Additionally, intellectual property issues and competitive interests can hinder open collaboration. Ethical considerations and public perception also vary widely, affecting policy decisions.
